Clinical Trials Browser

Active not recruiting × OTHER × Muscle-Invasive Bladder Carcinoma × Clear all

NCT04506554 2025-07-04

A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer

Phase 2 Active not recruiting

Muscle-Invasive Bladder Carcinoma